30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Episurf Medical Reaches Milestone of 500 Episealer Implants -

Episurf Medical is planning the 500th surgery with the Episealer® implant, which will occur in Germany. Episealer devices treat localized cartilage damage in the knee. The implants and associated surgical tools are approved under the CE Mark. At the end of 2018, the company announced FDA approval for its Investigational Device Exemption application to initiate a clinical trial of the Episealer knee implant; the two-year prospective, randomized, controlled, multi-center study will evaluate the device vs. microfracture in the treatment of focal femoral knee chondral or osteochondral lesions in 180 patients in the U.S. and Europe. (Episurf Medical AB, 2/20/19)